Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August 
Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review 
Telegram Restored on Apple App Store After Temporary Removal 
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations 
Apple Restores Telegram to App Store After Content Policy Violation 
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand 
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight 
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip 
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says 
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges 
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners 
Vast Eyes Hong Kong IPO as Chinese AI Unicorn Gains Momentum 
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits 
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves 
Capital One Says AML Review Led to Closure of Trump Organization Accounts 
WARSAW, Ind., April 09, 2018 -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, today announced it will continue its Diamond sponsorship for the 37th Annual European Paediatric Orthopaedic Society (EPOS) meeting, which will take place April 11 – 14 in Oslo, Norway. OrthoPediatrics has been a leading sponsor of the Society since the Company’s inception.
At the meeting, OrthoPediatrics will also sponsor a lunch symposium titled “Management of Open Fractures in Children”, featuring a panel of key opinion leaders from around the world. The panelists will discuss the most frequent types of fractures, guidelines for antibiotic use, evidence-based surgical treatment and the management of soft tissue injuries in open fractures in children. The panel will be moderated by Dr. Pierre Journeau, with additional discussion and case presentations by Drs. Annelie Weinberg, Manoj Ramachandran, and Manon Bachy.
OrthoPediatrics’ President & CEO Mark Throdahl, commented, “We are pleased to continue our leading support of EPOS, one of the world’s largest pediatric orthopedic scientific organizations. This society has remained steadfastly dedicated to elevating the quality of care for children with orthopedic conditions. OrthoPediatrics has shared this mission since our inception, and so we are proud to continue supporting the clinical education of pediatric surgeons as we work together to improve the lives of children with orthopedic conditions around the world.”
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 24 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This offering spans trauma & deformity, scoliosis and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 37 countries outside the United States.
Investor Contacts
The Ruth Group
Tram Bui / Emma Poalillo
(646) 536-7035 / 7024
[email protected] / [email protected]
